Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Real-World Effectiveness of Immunoglobulin Replacement Therapy on Hypogammaglobulinemia and Infectious Complications in Patients with Multiple Myeloma

Elizabeth K. O'Donnell, Thais Gift, Zaid Yousif, Lynn Huynh, Raj Desai, Gregory Belsky, Yichuan Hsieh, Nikhil Khandelwal, Mei Sheng Duh, Shawn Murphy, Marie Sanchirico

Blood (2024) 144 (Supplement 1): 707.

https://doi.org/10.1182/blood-2024-203419

Published: 2024

Journal Articles

Real-World Effectiveness of Ravulizumab Among Adults with Atypical Hemolytic Uremic Syndrome (aHUS) Who Switched to Ravulizumab within 3 Months of Eculizumab Treatment: A Physician Panel-Based Chart Review Study (aHUS IMPACT)

Shruti Chaturvedi, Yan Wang, Moh-Lim Ong, Arpita Nag, Rui Song, Lynn Huynh, Jordan A. Burdeau, Mei Sheng Duh, Ramy Magdy Hanna

Blood (2024) 144 (Supplement 1): 2613.

https://doi.org/10.1182/blood-2024-194225

Published: 2024

Journal Articles

Correlation between Real-World Progression-Free Survival (rwPFS) and Overall Survival (OS) in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Relapsed or Are Refractory, Intolerant, Resistant to Treatment with a Bruton's Tyrosine Kinase Inhibitor (BTKi)

Kevin H. Lin, Lynn Huynh, Xiaoqin Yang, Enrico Zanardo, Lisa Matay, Megan Pinaire, Daria Liborski, Mikaela M. McDonough, Jillian Foreman, Mohammed Z.H. Farooqui, Enrico De Nigris, Shravanthi R. Gandra, Eric M. Sarpong, Mei Sheng Duh, Jennifer R. Brown, Matthew S Davids

Blood (2023) 142 (Supplement 1): 4652.

https://doi.org/10.1182/blood-2023-180793

Published: 2023

Journal Articles

Real-World Impact of Luspatercept on Patients with Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions and with Prior Exposure to Erythropoietin-Stimulating Agents: A United States Healthcare Claims Database Study

Kashyap Patel, Kirollos S. Hanna, Enrico Zanardo, Ali McBride, Victoria Barghout, Rui Song, Lynn Huynh, Derek Tang, Mihran Yenikomshian, Leslie A. Andritsos

Blood (2023) 142 (Supplement 1): 916.

https://doi.org/10.1182/blood-2023-173364

Published: 2023

Journal Articles

Effectiveness of Chemo-Immunotherapy (CIT) and Novel Therapies in Second or Later Line of Therapy (2L+) for Patients with Relapsed/Refractory (R/R) Aggressive Large B-Cell Lymphoma (LBCL)

Blood (2023) 142 (Supplement 1): 309.

https://doi.org/10.1182/blood-2023-174497

Published: 2023

Journal Articles

Infection Outcomes and Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Treated with Immunoglobulin Replacement Therapy

Jacob Soumerai, Thais Gift, Zaid Yousif, Raj Desai, Lynn Huynh, Gregory Belsky, Mei Sheng Duh, Marie Sanchirico

Blood (2023) 142 (Supplement 1): 3280.

https://doi.org/10.1182/blood-2023-179458

Published: 2023

Journal Articles

Infection Outcomes and Hypogammaglobulinemia in Patients with Non-Hodgkin Lymphoma Treated with Immunoglobulin Replacement Therapy

Jacob Soumerai, Zaid Yousif, Thais Gift, Raj Desai, Lynn Huynh, Caitlin Haven, Mei Sheng Duh, Marie Sanchirico

Blood (2023) 142 (Supplement 1): 3040.

https://doi.org/10.1182/blood-2023-187068

Published: 2023

Journal Articles

Clinical Characteristics, Treatment Patterns, and Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Refractory to Covalent Bruton's Tyrosine Kinase Inhibitor (BTKi) and Exposed to B-Cell Lymphoma 2 Inhibitor (BCL2i)

Blood (2023) 142 (Supplement 1): 1910.

https://doi.org/10.1182/blood-2023-182188

Published: 2023

Journal Articles

Real-World Retrospective Study of Non-Transfusion Dependent Patients with Myelodysplastic Syndromes Treated with Luspatercept: A Healthcare Claims Database Study

Leslie A. Andritsos, Kirollos S. Hanna, Enrico Zanardo, Ali McBride, Victoria Barghout, Rui Song, Lynn Huynh, Derek Tang, Mihran Yenikomshian, Kashyap Patel

Blood (2023) 142 (Supplement 1): 3808.

https://doi.org/10.1182/blood-2023-173375

Published: 2023

Journal Articles

Treatment Patterns, Tolerance, and Clinical Response of Chronic Phase Chronic Myeloid Leukemia (CML-CP) Patients (Including Those Harboring the T315I Mutation) Experiencing Multiple Tyrosine Kinase Inhibitor Failure: A Multi-Center Retrospective Chart Review Analysis

Franck E. Nicolini, Francoise Huguet, Lynn Huynh, Churong Xu, Christophe Bouvier, Aurore Yocolly, Gabriel Etienne

Blood (2022) 140 (Supplement 1): 9656–9658.

https://doi.org/10.1182/blood-2022-160268

Published: 2022

Journal Articles

Patient Characteristics, Treatment Patterns, and Outcomes Following Covalent Btki Discontinuation in a Contemporary Cohort of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Patients

Kevin H. Lin, Lynn Huynh, Xiaoqin Yang, Neema Lema, Lisa Matay, Sobana Balasubramanian, Daria Liborski, Mikaela M. McDonough, Jillian Foreman, Mohammed Z.H. Farooqui, Enrico De Nigris, Shravanthi R. Gandra, Eric Sarpong, Mei Sheng Duh, Jennifer R. Brown, Matthew S. Davids

Blood (2022) 140 (Supplement 1): 4150–4152.

https://doi.org/10.1182/blood-2022-160389

Published: 2022

Journal Articles

A Matching-Adjusted Indirect Comparison of the Efficacy of Pegcetacoplan Using Prince Trial Data Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria

Raymond Wong, Jesse Fishman, Koo Wilson, Mohammed Al-Adhami, Michael Yeh, Zalmai Hakimi, Christopher Yee, Lynn Huynh, Mei Sheng Duh

Blood (2022) 140 (Supplement 1): 11435–11437.

https://doi.org/10.1182/blood-2022-160197

Published: 2022

Journal Articles

Real-World Clinical Burden of Sickle Cell Disease in the US Community-Practice Setting: A Single-Center Experience from the Foundation for Sickle Cell Disease Research

Lanetta Bronté-Hall, MPH, MSPH, MD, Matthew Parkin, Courtney Green, Elsa Tchouambou, DO, Lynn Huynh, MPH, MBA, DrPH, Charu Puri-Sharma, MS, Rose Chang, MSPH, MS, ScD, Anjulika Chawla, MD, James Signorovitch, PhD, Gershwin Theophilus Blyden, MD

Blood (2019) 134 (Supplement_1): 5856.

https://doi.org/10.1182/blood-2019-128700

Published: 2019

Journal Articles

A Retrospective Chart Review to Assess Burden of Illness Among Patients with Severe Aplastic Anemia with Insufficient Response to Immunosuppressive Therapy

Regis Peffault De Latour, MD PhD, Lynn Huynh, Jasmina I. Ivanova, Todor Totev, BSc, Mehmet Bilginsoy, BA, Joseph H. Antin, MD, Anuja Roy, PhD, Mei Sheng Duh, MPH, ScD

Blood (2017) 130 (Supplement 1): 678.

https://doi.org/10.1182/blood.V130.Suppl_1.678.678

Published: 2017

Journal Articles

Treatment Characteristics and Deep Molecular Response in Chronic Phase - Chronic Myeloid Leukemia Patients Treated with Second-Line Nilotinib or Dasatinib: A Multi-Country Retrospective Chart Review Study

Jorge E. Cortes, MD, Lynn Huynh, Estella Mendelson, PhD, Patricia Brandt, PhD, Darshan Dalal, MPH, MD PhD, Maral Dersarkissian, PhD, Diego Cortina, MD MSc, Sahil Narkhede, BA, Mei Sheng Duh, MPH, ScD

Blood (2017) 130 (Supplement 1): 2897.

https://doi.org/10.1182/blood.V130.Suppl_1.2897.2897

Published: 2017

Journal Articles

Value of Transfusion Independence in Severe Aplastic Anemia from Patients' Perspectives - a Discrete Choice Experiment

A. Simon Pickard, PhD, Jasmina I. Ivanova, Lynn Huynh, MPH, MBA, DrPh, Todor Totev, BSc, Sophia Graham, BA, Axel C Mühlbacher, PhD, Anuja Roy, Mei Sheng Duh

Blood (2016) 128 (22): 5077.

https://doi.org/10.1182/blood.V128.22.5077.5077

Published: 2016

Journal Articles

Medical Complications In Patients With Myelofibrosis By Frequency Of Blood Transfusion and Iron Chelation Therapy

Francis Vekeman, MA, Wendy Y Cheng, MPH, MPhil, Medha Sasane, BPharm, PhD, Lynn Huynh, MPH, MBA, DrPH, Michael Kaminsky, BA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Ruben A. Mesa, MD

Blood (2013) 122 (21): 2964.

https://doi.org/10.1182/blood.V122.21.2964.2964

Published: 2013

NARROW

Real-World Effectiveness of Immunoglobulin Replacement Therapy on Hypogammaglobulinemia and Infectious Complications in Patients with Multiple Myeloma

Real-World Effectiveness of Ravulizumab Among Adults with Atypical Hemolytic Uremic Syndrome (aHUS) Who Switched to Ravulizumab within 3 Months of Eculizumab Treatment: A Physician Panel-Based Chart Review Study (aHUS IMPACT)

Correlation between Real-World Progression-Free Survival (rwPFS) and Overall Survival (OS) in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Relapsed or Are Refractory, Intolerant, Resistant to Treatment with a Bruton's Tyrosine Kinase Inhibitor (BTKi)

Real-World Impact of Luspatercept on Patients with Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions and with Prior Exposure to Erythropoietin-Stimulating Agents: A United States Healthcare Claims Database Study

Effectiveness of Chemo-Immunotherapy (CIT) and Novel Therapies in Second or Later Line of Therapy (2L+) for Patients with Relapsed/Refractory (R/R) Aggressive Large B-Cell Lymphoma (LBCL)

Infection Outcomes and Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Treated with Immunoglobulin Replacement Therapy

Infection Outcomes and Hypogammaglobulinemia in Patients with Non-Hodgkin Lymphoma Treated with Immunoglobulin Replacement Therapy

Clinical Characteristics, Treatment Patterns, and Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Refractory to Covalent Bruton's Tyrosine Kinase Inhibitor (BTKi) and Exposed to B-Cell Lymphoma 2 Inhibitor (BCL2i)

Real-World Retrospective Study of Non-Transfusion Dependent Patients with Myelodysplastic Syndromes Treated with Luspatercept: A Healthcare Claims Database Study

Treatment Patterns, Tolerance, and Clinical Response of Chronic Phase Chronic Myeloid Leukemia (CML-CP) Patients (Including Those Harboring the T315I Mutation) Experiencing Multiple Tyrosine Kinase Inhibitor Failure: A Multi-Center Retrospective Chart Review Analysis

Patient Characteristics, Treatment Patterns, and Outcomes Following Covalent Btki Discontinuation in a Contemporary Cohort of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Patients

A Matching-Adjusted Indirect Comparison of the Efficacy of Pegcetacoplan Using Prince Trial Data Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria

Real-World Clinical Burden of Sickle Cell Disease in the US Community-Practice Setting: A Single-Center Experience from the Foundation for Sickle Cell Disease Research

A Retrospective Chart Review to Assess Burden of Illness Among Patients with Severe Aplastic Anemia with Insufficient Response to Immunosuppressive Therapy

Treatment Characteristics and Deep Molecular Response in Chronic Phase - Chronic Myeloid Leukemia Patients Treated with Second-Line Nilotinib or Dasatinib: A Multi-Country Retrospective Chart Review Study

Value of Transfusion Independence in Severe Aplastic Anemia from Patients' Perspectives - a Discrete Choice Experiment

Medical Complications In Patients With Myelofibrosis By Frequency Of Blood Transfusion and Iron Chelation Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only